Oleanolic acid suppresses the proliferation of human bladder cancer by Akt/mTOR/S6K and ERK1/2 signaling

被引:2
|
作者
Mu, Da-Wei [1 ]
Guo, He-Qing [1 ]
Zhou, Gao-Biao [1 ]
Li, Jian-Ye [1 ]
Su, Bin [1 ]
机构
[1] Air Force Gen Hosp, Dept Urol, Beijing 100142, Peoples R China
关键词
Oleanolic acid; bladder cancer; Akt; mTOR; S6K; ERK1/2; NF-KAPPA-B; ALZHEIMERS-DISEASE; APOPTOSIS; CELLS; BRAIN; DYSFUNCTION; MODEL; RISK; JNK;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oleanolic acid has significant pharmacological activities, such as anti-tumor, regulating blood sugar level and liver protection, which are more effective compared with free aglyconeoleanolic acid. However, it is still unknown if oleanolic acid affects the proliferation of human bladder cancer. We utilized T24 cells to study the effect of oleanolic acid on the proliferation and apoptosis of human bladder cancer. In this study, we found that the anticancer effect of oleanolic acid significantly suppressed cell proliferation and increased apoptosis and caspase-3 activity of T24 cells. Furthermore, Akt, mTOR and S6K protein expression was greatly inhibited in T24 cells under oleanolic acid treatment. Meanwhile, ERK1/2 of phosphorylation protein expression was significantly promoted by oleanolic acid treatment. Taken together, we provided evidences that oleanolic acid was Akt/mTOR/S6K and ERK1/2 signaling-targeting anti-tumor agent. These findings represent new evidences that oleanolic acid suppresses the proliferation of human bladder cancer by Akt/mTOR/S6K and ERK1/2 signaling, and oleanolic acid may be used to prevent human bladder cancer.
引用
收藏
页码:13864 / 13870
页数:7
相关论文
共 50 条
  • [1] Inhibition of Human Lung Cancer Cell Proliferation and Survival by Post-Exercise Serum Is Associated with the Inhibition of Akt, mTOR, p70 S6K, and Erk1/2
    Kurgan, Nigel
    Tsakiridis, Evelyn
    Kouvelioti, Rozalia
    Moore, Jessy
    Klentrou, Panagiota
    Tsiani, Evangelia
    CANCERS, 2017, 9 (05)
  • [2] Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy
    Shinojima, Naoki
    Yokoyama, Tomohisa
    Kondo, Yasuko
    Kondo, Seiji
    AUTOPHAGY, 2007, 3 (06) : 635 - 637
  • [3] mTOR, p70S6K, AKT, and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids
    Gagliano, Teresa
    Bellio, Mariaenrica
    Gentilin, Erica
    Mole, Daniela
    Tagliati, Federico
    Schiavon, Marco
    Cavallesco, Narciso Giorgio
    Andriolo, Luigi Gaetano
    Ambrosio, Maria Rosaria
    Rea, Federico
    degli Uberti, Ettore
    Zatelli, Maria Chiara
    ENDOCRINE-RELATED CANCER, 2013, 20 (04) : 463 - 475
  • [4] Limocitrin Suppresses Breast Cancer Through Inducing Apoptotic-Cell Death Signaling and Inhibiting the PI3K/AKT/mTOR/S6K Cell Survival Signaling
    Lim, Hyung-Jin
    Bae, Jaehoon
    Bak, Seon-Gyeong
    Chandimali, Nisansala
    Park, Eun Hyun
    Park, Sang-Ik
    Tachibana, Hirofumi
    Won, Yeong-Seon
    Lee, Seung-Jae
    JOURNAL OF MEDICINAL FOOD, 2023, 26 (10) : 749 - 759
  • [5] "Huanglianjiedu Decoction" Against Pancreatic Adenocarcinoma Proliferation of by Downregulating the PI3K/AKT/mTOR and MAPK/ERK1/2 Signaling Pathways
    Dong, Shu
    Xu, Panling
    Yang, Peiwen
    Jiao, Juying
    Cheng, Chien-shan
    Chen, Lianyu
    JOURNAL OF EVIDENCE-BASED INTEGRATIVE MEDICINE, 2024, 29
  • [6] EXTRACARDIAC RHABDOMYOMAS - PRESENTATION OF TWO CASES WITH ANALYSIS OF AKT/mTOR AND ERK1/2 SIGNALING
    Izycka-Swieszewska, Ewa
    Wesolowski, Wojciech
    Hermann, Blanka
    POLISH JOURNAL OF PATHOLOGY, 2015, 66 (02) : 195 - 199
  • [7] Delphinidin suppresses proliferation and migration of human ovarian clear cell carcinoma cells through blocking AKT and ERK1/2 MAPK signaling pathways
    Lim, Whasun
    Jeong, Wooyoung
    Song, Gwonhwa
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2016, 422 (0C) : 172 - 181
  • [8] Grifolin induces autophagic cell death by inhibiting the Akt/mTOR/S6K pathway in human ovarian cancer cells
    Che, Xiaoxia
    Yan, Hong
    Sun, Hengzi
    Dongol, Samina
    Wang, Yilin
    Lv, Qingtao
    Jiang, Jie
    ONCOLOGY REPORTS, 2016, 36 (02) : 1041 - 1047
  • [9] PI3K/AKT and mTOR/p70S6K1 Signaling Pathways in Human Cancer
    Jiang, Bing-Hua
    CURRENT CANCER DRUG TARGETS, 2013, 13 (03) : 233 - 233
  • [10] CSNK1G2 differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells
    Hoang, Anh Thu Nguyen
    Hoe, Kwang-Lae
    Lee, Sook-Jeong
    PLOS ONE, 2021, 16 (04):